Trimazosin

CARDIOVASCULAR SYSTEM

Key facts

Trimazosin is a drug catalogued in DrugCentral. Recorded indications include Hypertensive disorder.

• Indications: Hypertensive disorder.
• ATC code: C02CA03 (Alpha-adrenoreceptor antagonists).
• Molecular formula: C20H29N5O6; molecular weight 435.48 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Hypertensive disorder

ATC classification

ATC code	Therapeutic hierarchy
C02CA03	CARDIOVASCULAR SYSTEM › ANTIHYPERTENSIVES › ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING › Alpha-adrenoreceptor antagonists

Chemical structure

• Molecular formula: C₂₀H₂₉N₅O₆
• Molecular weight: 435.48 g/mol
• CAS number: 35795-16-5
• InChIKey: YNZXWQJZEDLQEG-UHFFFAOYSA-N
• PubChem CID: 37264

COC1=C(OC)C(OC)=C2N=C(N=C(N)C2=C1)N1CCN(CC1)C(=O)OCC(C)(C)O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Trimazosin used for?

DrugCentral lists the following indications for Trimazosin: Hypertensive disorder.

What is the chemical formula of Trimazosin?

Trimazosin has the molecular formula C20H29N5O6 and a molecular weight of 435.48 g/mol.

Sources

• DrugCentral drug card 2747 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL3989848 — compound record and bioactivity
• PubChem CID 37264 — chemical identifiers
• DrugBank DB09206 — drug record
• FDA UNII 31L760807H — substance identity

How this page is built: methodology · editorial policy & corrections.